Business Description
Coral Laboratories Ltd
ISIN : INE683E01017
Share Class Description:
BOM:524506: Shs DematerialisedCompare
Compare
Traded in other countries / regions
524506.India IPO Date
2001-12-26Description
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhaler, injectable, drops, sprays, special kits, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 54.18 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.11 | |||||
| Interest Coverage | 323.29 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.43 | |||||
| Beneish M-Score | -2.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.5 | |||||
| 3-Year EBITDA Growth Rate | -1.3 | |||||
| 3-Year EPS without NRI Growth Rate | -3.3 | |||||
| 3-Year Book Growth Rate | 10.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 95.06 | |||||
| 9-Day RSI | 90.86 | |||||
| 14-Day RSI | 85.7 | |||||
| 6-1 Month Momentum % | -8.02 | |||||
| 12-1 Month Momentum % | 60.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.03 | |||||
| Quick Ratio | 7.38 | |||||
| Cash Ratio | 4.63 | |||||
| Days Inventory | 154.97 | |||||
| Days Sales Outstanding | 193.41 | |||||
| Days Payable | 87.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 3.78 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.09 | |||||
| Operating Margin % | 8.72 | |||||
| Net Margin % | 13.81 | |||||
| FCF Margin % | 16.25 | |||||
| ROE % | 5.6 | |||||
| ROA % | 4.68 | |||||
| ROIC % | 3.61 | |||||
| ROC (Joel Greenblatt) % | 13.03 | |||||
| ROCE % | 6.62 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.5 | |||||
| PE Ratio without NRI | 20.5 | |||||
| Shiller PE Ratio | 13 | |||||
| Price-to-Owner-Earnings | 15.1 | |||||
| PS Ratio | 2.83 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 1.09 | |||||
| Price-to-Free-Cash-Flow | 17.43 | |||||
| Price-to-Operating-Cash-Flow | 14.75 | |||||
| EV-to-EBIT | 9.57 | |||||
| EV-to-EBITDA | 8.05 | |||||
| EV-to-Revenue | 1.65 | |||||
| EV-to-FCF | 10.16 | |||||
| Price-to-Projected-FCF | 1.24 | |||||
| Price-to-Median-PS-Value | 1.94 | |||||
| Price-to-Graham-Number | 1.07 | |||||
| Price-to-Net-Current-Asset-Value | 1.68 | |||||
| Price-to-Net-Cash | 3.55 | |||||
| Earnings Yield (Greenblatt) % | 10.45 | |||||
| FCF Yield % | 5.74 | |||||
| Forward Rate of Return (Yacktman) % | -7.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coral Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 659.869 | ||
| EPS (TTM) (₹) | 25.51 | ||
| Beta | 1.5 | ||
| Volatility % | 54.15 | ||
| 14-Day RSI | 85.7 | ||
| 14-Day ATR (₹) | 24.05681 | ||
| 20-Day SMA (₹) | 387.495 | ||
| 12-1 Month Momentum % | 60.77 | ||
| 52-Week Range (₹) | 227.1 - 541.4 | ||
| Shares Outstanding (Mil) | 3.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coral Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coral Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Coral Laboratories Ltd Frequently Asked Questions
What is Coral Laboratories Ltd(BOM:524506)'s stock price today?
The current price of BOM:524506 is ₹522.95. The 52 week high of BOM:524506 is ₹541.40 and 52 week low is ₹227.10.
When is next earnings date of Coral Laboratories Ltd(BOM:524506)?
The next earnings date of Coral Laboratories Ltd(BOM:524506) is .
Does Coral Laboratories Ltd(BOM:524506) pay dividends? If so, how much?
Coral Laboratories Ltd(BOM:524506) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers